Ju Du
Impact in
- Biomaterials top 2%
- Nanoparticle-Based Drug Delivery
- Pharmaceutical Science top 2%
- Advanced Drug Delivery Systems
Papers in
-
- Inhalation and Respiratory Drug Delivery 7
-
- RNA Interference and Gene Delivery 3
- Cancer therapeutics and mechanisms 2
- Advanced biosensing and bioanalysis techniques 2
- Co-authors
- Wan-Liang Lü (7 shared papers)Xue Ying (4 shared papers)Jinning Lou (4 shared papers)Hugh D. C. Smyth (6 shared papers)Jia Guo (6 shared papers)Wei Tian (3 shared papers)Ruo‐Jing Li (3 shared papers)Ying Men (4 shared papers)
- Journals
- AAPS PharmSciTech (2 papers)European Journal of Pharmaceutics and Biopharmaceutics (2 papers)Molecular Pharmaceutics (2 papers)Journal of Controlled Release (2 papers)Urologic Oncology Seminars and Original Investigations (1 paper)
- Partner nations
- ChinaUnited StatesSingapore
In The Last Decade
Ju Du
17 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 91
- Biomaterials 647
- Pharmaceutical Science 170
- Polymers and Plastics 150
- Molecular Medicine 44
- Molecular Biology 594
Countries citing papers authored by Ju Du
This map shows the geographic impact of Ju Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju Du more than expected).
Fields of papers citing papers by Ju Du
This network shows the impact of papers produced by Ju Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju Du. The network helps show where Ju Du may publish in the future.
Co-authors
The 25 scholars most cited alongside Ju Du, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 407 | |
| 2 | 2010 | 279 | |
| 3 | 2009 | 138 | |
| 4 | 2008 | 107 | |
| 5 | 2015 | 60 | |
| 6 | 2010 | 59 | |
| 7 | 2012 | 57 | |
| 8 | 2014 | 47 | |
| 9 | 2014 | 31 | |
| 10 | 2016 | 24 | |
| 11 | 2015 | 19 | |
| 12 | 2013 | 18 | |
| 13 | 2008 | 10 | |
| 14 | 2015 | 9 | |
| 15 | 2024 | 8 | |
| 16 | [Relationship between CCL20/CCR6/Th17 axis and vascular invasion and metastasis in patients with primary hepatocellular carcinoma]. | 2015 | 3 |
| 17 | 2008 | 2 |
About Ju Du
Ju Du is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Pharmaceutical Science, Biomaterials and Oncology, having authored 17 papers that have together received 1.3k indexed citations. Recurring topics across this work include Inhalation and Respiratory Drug Delivery (7 papers), Nanoparticle-Based Drug Delivery (4 papers), RNA Interference and Gene Delivery (3 papers), Drug Solubulity and Delivery Systems (3 papers), Advanced Drug Delivery Systems (3 papers), Cancer therapeutics and mechanisms (2 papers), Advanced biosensing and bioanalysis techniques (2 papers) and Nanoplatforms for cancer theranostics (2 papers). The work is most often cited by research in Biomaterials (647 citations), Pharmaceutical Science (170 citations), Polymers and Plastics (150 citations), Molecular Medicine (44 citations) and Molecular Biology (594 citations). Ju Du has collaborated with scholars based in China, United States and Singapore. Frequent co-authors include Wan-Liang Lü, Xue Ying, Jinning Lou, Hugh D. C. Smyth, Jia Guo, Wei Tian, Ruo‐Jing Li, Ying Men, Qiang Zhang and Li Y. Their work appears in journals such as AAPS PharmSciTech, European Journal of Pharmaceutics and Biopharmaceutics, Molecular Pharmaceutics, Journal of Controlled Release and Urologic Oncology Seminars and Original Investigations.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.